Clinical Trial Update: Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of ONCOFID-P-B (paclitaxel-hyaluronic acid) for bladder carcinoma in situ is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Carcinoma in Situ

Drugs mentioned

• ONCOFID-P-B (paclitaxel-hyaluronic acid)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Bladder Carcinoma in Situ (CIS) | Phase 3 | Status: RECRUITING